Brief: Cti Biopharma Q2 Loss Per Share $0.21

CTI Biopharma

08/08/2022 23:33

Aug 8 (Reuters) - CTI Biopharma Corp  CTIC.O :
    * CTI BIOPHARMA REPORTS SECOND QUARTER 2022 FINANCIAL
RESULTS
    * Q2 LOSS PER SHARE $0.21
    * QTRLY NET PRODUCT SALES OF $12.3 MILLION
    * Q2 EARNINGS PER SHARE VIEW $-0.20, REVENUE VIEW $9.1
MILLION --
REFINITIV IBES DATA

Source text for Eikon:  ID:nPnKZS6Ja 
Further company coverage:  CTIC.O 

 ((Reuters.Briefs@thomsonreuters.com;))